1. Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study. Issue 1 (January 2017) Authors: Rudin, Charles M; Pietanza, M Catherine; Bauer, Todd M; Ready, Neal; Morgensztern, Daniel; Glisson, Bonnie S; Byers, Lauren A; Johnson, Melissa L; Burris, Howard A; Robert, Francisco; Han, Tae H; Bheddah, Sheila; Theiss, Noah; Watson, Sky; Mathur, Deepan; Vennapusa, Bharathi; Zayed, Hany; Lally, ... Journal: Lancet oncology Issue: Volume 18:Issue 1(2017:Jan.) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer. (April 2017) Authors: Jones, Benjamin S.; Jerome, Mary S.; Miley, Deborah; Jackson, Bradford E.; DeShazo, Mollie R.; Reddy, Vishnu V.B.; Singh, Karan P.; Brown, Olivia C.; Robert, Francisco Journal: Lung cancer Issue: Volume 106(2017) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors. (22nd September 2021) Authors: Do, Khanh T.; Chow, Laura Quan Man; Reckamp, Karen; Sanborn, Rachel E.; Burris, Howard; Robert, Francisco; Camidge, D. Ross; Steuer, Conor E.; Strickler, John H.; Weise, Amy; Specht, Jennifer M.; Gutierrez, Martin; Haughney, Peter; Hengel, Shawna; Derleth, Christina Louise; Yap, Timothy A. Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Veliparib and nivolumab in combination with platinum doublet chemotherapy in patients with metastatic or advanced non-small cell lung cancer: A phase 1 dose escalation study. (November 2021) Authors: Clarke, Jeffrey M.; Patel, Jyoti D.; Robert, Francisco; Kio, Ebenezer A.; Thara, Eddie; Ross Camidge, D.; Dunbar, Martin; Nuthalapati, Silpa; Dinh, Minh H.; Bach, Bruce A. Journal: Lung cancer Issue: Volume 161(2021) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors. (22nd September 2021) Authors: Do, Khanh T.; Chow, Laura Quan Man; Reckamp, Karen; Sanborn, Rachel E.; Burris, Howard; Robert, Francisco; Camidge, D. Ross; Steuer, Conor E.; Strickler, John H.; Weise, Amy; Specht, Jennifer M.; Gutierrez, Martin; Haughney, Peter; Hengel, Shawna; Derleth, Christina Louise; Yap, Timothy A. Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗